Cyclic vomiting syndrome (CVS) is linked to migraines and may share common biological mechanisms, like hypothalamic activation and altered dopamine signaling.
Recent advancements in migraine treatments could also benefit CVS, despite limited research on their effectiveness for this condition.
The manuscript focuses on emerging migraine therapies, including CGRP-targeting drugs and neuromodulation devices, which might be helpful for treating CVS in the future.